Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
PIPF 031: A Treatment Protocol to Allow Patients in the US with Idiopathic Pulmonary Fibrosis Access to Pirfenidone
Trial ID or NCT#
NCT02141087
Status
NOT RECRUITING
Purpose
This is an open label multi-center program to allow patients in the US with IPF access to treatment with pirfenidone.
Investigator(s)
Kapilkumar Patel
Contact us to find out if this trial is right for you.
CONTACT
Tal Alfasi
(650) 736-8083
View on ClinicalTrials.gov
About this Clinical Trial
Your Message Will Go To
Tal Alfasi650-736-8083